Gables Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $378K | Buy |
2,990
+390
| +15% | +$51.4K | 0.14% | 110 |
|
|
2026
Q1 | $362K | Sell |
2,600
-600
| -19% | -$84K | 0.15% | 104 |
|
|
2025
Q4 | $393K | Hold |
3,200
| – | – | 0.17% | 98 |
|
|
2025
Q3 | $355K | Hold |
3,200
| – | – | 0.15% | 101 |
|
|
2025
Q2 | $355K | Sell |
3,200
-475
| -13% | -$50.6K | 0.17% | 99 |
|
|
2025
Q1 | $412K | Hold |
3,675
| – | – | 0.2% | 87 |
|
|
2024
Q4 | $339K | Sell |
3,675
-775
| -17% | -$69.8K | 0.16% | 98 |
|
|
2024
Q3 | $373K | Sell |
4,450
-735
| -14% | -$56.1K | 0.19% | 92 |
|
|
2024
Q2 | $356K | Sell |
5,185
-850
| -14% | -$56.7K | 0.19% | 91 |
|
|
2024
Q1 | $442K | Sell |
6,035
-450
| -7% | -$34.6K | 0.24% | 81 |
|
|
2023
Q4 | $525K | Sell |
6,485
-50
| -0.8% | -$3.89K | 0.33% | 66 |
|
|
2023
Q3 | $490K | Sell |
6,535
-600
| -8% | -$46.1K | 0.34% | 67 |
|
|
2023
Q2 | $550K | Buy |
7,135
+85
| +1% | +$6.78K | 0.36% | 63 |
|
|
2023
Q1 | $585K | Hold |
7,050
| – | – | 0.41% | 57 |
|
|
2022
Q4 | $605K | Buy |
7,050
+100
| +1% | +$7.92K | 0.44% | 55 |
|
|
2022
Q3 | $429K | Sell |
6,950
-100
| -1% | -$6.31K | 0.34% | 68 |
|
|
2022
Q2 | $436K | Hold |
7,050
| – | – | 0.33% | 70 |
|
|
2022
Q1 | $419K | Sell |
7,050
-50
| -0.7% | -$3.2K | 0.26% | 86 |
|
|
2021
Q4 | $516K | Sell |
7,100
-700
| -9% | -$48.2K | 0.31% | 75 |
|
|
2021
Q3 | $545K | Sell |
7,800
-1,525
| -16% | -$107K | 0.36% | 68 |
|
|
2021
Q2 | $642K | Sell |
9,325
-3,939
| -30% | -$263K | 0.44% | 58 |
|
|
2021
Q1 | $857K | Hold |
13,264
| – | – | 0.47% | 59 |
|
|
2020
Q4 | $773K | Hold |
13,264
| – | – | 0.45% | 58 |
|
|
2020
Q3 | $838K | Sell |
13,264
-350
| -3% | -$24.3K | 0.54% | 48 |
|
|
2020
Q2 | $1.05M | Buy |
13,614
+171
| +1% | +$13.1K | 0.73% | 39 |
|
|
2020
Q1 | $1.01M | Buy |
13,443
+54
| +0.4% | +$3.73K | 0.83% | 34 |
|
|
2019
Q4 | $866K | Buy |
13,389
+500
| +4% | +$32.6K | 0.58% | 49 |
|
|
2019
Q3 | $819K | Hold |
12,889
| – | – | 0.58% | 51 |
|
|
2019
Q2 | $869K | Sell |
12,889
-100
| -0.8% | -$6.58K | 0.71% | 42 |
|
|
2019
Q1 | $844K | Sell |
12,989
-1,700
| -12% | -$113K | 0.68% | 44 |
|
|
2018
Q4 | $919K | Sell |
14,689
-700
| -5% | -$48.9K | 0.8% | 38 |
|
|
2018
Q3 | $1.19M | Sell |
15,389
-400
| -3% | -$30.2K | 0.9% | 35 |
|
|
2018
Q2 | $1.1M | Sell |
15,789
-500
| -3% | -$35.3K | 0.9% | 37 |
|
|
2018
Q1 | $1.23M | Buy |
+16,289
| New | +$1.29M | 1.09% | 29 |
|
Other funds holding GILD
Gables Capital Management's GILD Position: Q2 2026 in Review
Gables Capital Management increased its Gilead Sciences (GILD) stake by 15% in Q2 2026, buying an estimated $51.4K and bringing the position to 2,990 shares worth $378K. The position accounts for 0.14% of the portfolio, ranked #110.
Gables Capital Management first reported a position in GILD in Q1 2018 and has held it in 34 quarters since. The position peaked at $1.23M in Q1 2018. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Gables Capital Management held 2,990 shares of Gilead Sciences worth $378K as of Q2 2026.
- Gables Capital Management bought 390 Gilead Sciences shares in Q2 2026, an estimated $51.4K.
- Gilead Sciences made up 0.14% of Gables Capital Management's portfolio in Q2 2026, its #110 holding.
- Gables Capital Management first reported a position in Gilead Sciences in Q1 2018 and has held it in 34 quarters since.
- Gables Capital Management's Gilead Sciences position peaked at $1.23M in Q1 2018.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Gables Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.